Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Reynolds

Showing results (151-160 of 212) with videos related to

Pageof 22
Sort By:
Pediatric Blood & Cancer|March 14, 2014
Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing programMin H Kang, C Patrick Reynolds, John M Maris, et al.
Pediatric Blood & Cancer|May 31, 2016
Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing ProgramMin H Kang, C Patrick Reynolds, E Anders Kolb, et al.
Pediatric Blood & Cancer|November 5, 2011
Initial testing (stage 1) of SGI-1776, a PIM1 kinase inhibitor, by the pediatric preclinical testing programVandana Batra, John M Maris, Min H Kang, et al.
Pediatric Blood & Cancer|January 22, 2013
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing programStephen T Keir, John M Maris, C Patrick Reynolds, et al.
Science Translational Medicine|August 19, 2021
ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156Balakrishna Koneru, Ahsan Farooqi, Thinh H Nguyen, et al.
Pediatric Blood & Cancer|March 26, 2014
Initial testing (stage 1) of the notch inhibitor PF-03084014, by the pediatric preclinical testing programHernan Carol, John M Maris, Min H Kang, et al.
Pediatric Blood & Cancer|June 26, 2009
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing programRichard Gorlick, E Anders Kolb, Peter J Houghton, et al.
Pediatric Blood & Cancer|April 5, 2013
Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, C Patrick Reynolds, et al.
Pediatric Blood & Cancer|September 1, 2010
Initial testing (stage 1) of AZD6244 (ARRY-142886) by the Pediatric Preclinical Testing ProgramE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium studyLars M Wagner, Judith G Villablanca, Clinton F Stewart, et al.
Pageof 22

Showing results (151-160 of 212) with videos related to

Sort By:
Pageof 22
Pediatric Blood & Cancer|March 14, 2014
Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing programMin H Kang, C Patrick Reynolds, John M Maris, et al.
Pediatric Blood & Cancer|May 31, 2016
Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing ProgramMin H Kang, C Patrick Reynolds, E Anders Kolb, et al.
Pediatric Blood & Cancer|November 5, 2011
Initial testing (stage 1) of SGI-1776, a PIM1 kinase inhibitor, by the pediatric preclinical testing programVandana Batra, John M Maris, Min H Kang, et al.
Pediatric Blood & Cancer|January 22, 2013
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing programStephen T Keir, John M Maris, C Patrick Reynolds, et al.
Science Translational Medicine|August 19, 2021
ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156Balakrishna Koneru, Ahsan Farooqi, Thinh H Nguyen, et al.
Pediatric Blood & Cancer|March 26, 2014
Initial testing (stage 1) of the notch inhibitor PF-03084014, by the pediatric preclinical testing programHernan Carol, John M Maris, Min H Kang, et al.
Pediatric Blood & Cancer|June 26, 2009
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing programRichard Gorlick, E Anders Kolb, Peter J Houghton, et al.
Pediatric Blood & Cancer|April 5, 2013
Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, C Patrick Reynolds, et al.
Pediatric Blood & Cancer|September 1, 2010
Initial testing (stage 1) of AZD6244 (ARRY-142886) by the Pediatric Preclinical Testing ProgramE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium studyLars M Wagner, Judith G Villablanca, Clinton F Stewart, et al.
Pageof 22